A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Relapsed/Refractory DLBCL

Myron S. Czuczman, Andrew Davies, Kim M. Linton, Nina Wagner-Johnston, Randy D. Gascoyne, David A. Eberhard, Gilles Salles, Thomas E. Witzig, Pier Luigi Zinzani, George W. Wright, Louis M. Staudt, Jacqueline Repici, Dale Song, Oliver Manzke, Ian D. Lewis

Research output: Contribution to journalArticlepeer-review

Cite this